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Despite the longstanding use of dried mushrooms and mushroom extracts in traditional
Chinese medicine, there is no scientific evidence to support the effectiveness of these prep-
arations in the treatment of human disease. Consumers should evaluate assertions made
by companies about the miraculous properties of medicinal mushrooms very critically. The
potential harm caused by these natural products is another important consideration. In
a more positive vein, the presence of potent toxins and neurotropic compounds in basid-
iomycete fruit bodies suggests that secondary metabolites with useful pharmacological
properties are widespread in these fungi. Major investment in controlled experiments
and objective clinical trials is necessary to develop this natural pharmacopeia.
ª 2016 The Author. Published by Elsevier Ltd on behalf of The British Mycological Society.
This is an open access article under the CC BY license (http://creativecommons.org/
licenses/by/4.0/).Mushrooms have featured in traditional Chinese medicine for
centuries and dried extracts from fruit bodies occupy a lucra-
tive segment of the market for herbal medicines in western
countries. The advertising of these natural products in North
America and Europe is poorly regulated, allowing companies
to make fictitious statements about the medicinal benefits of
mushrooms. A number of issues must be considered objec-
tively to assess this controversial topic. We begin with the tra-
ditional uses of mushrooms in Chinese medicine.
Medicinal use of the shitake mushroom, Lentinula edodes,
became widespread in the Ming Dynasty (1368e1644) after
the development of methods for cultivating the fungus on
logs (Jones 1995). Shiitake was adopted as a tonic that could
counteract the quotidian aches, pains, and fatigue associatedlsevier Ltd on behalf of Th
rg/licenses/by/4.0/).with aging. More specific virtues of shiitake were supposed to
include its promotion of heart health and efficacy against lung
disease and intestinal worms. It also became associated with
the treatment of cancer. There is little experimental support
for any of these qualities. Contemporary advocates of medic-
inal mushrooms argue that this dissonance is rooted in a mis-
match in philosophy between Chinese andWesternmedicine.
Traditional Chinese medicine treats symptoms of cardio-
vascular disease, for example, as a manifestation of an imbal-
ancebetweenmultiplephysiologicalprocesses inan individual
patient. Treatments, including acupuncture and herbal medi-
cines, are designed to restore balance to the ‘flow of energy’
in the body. (‘Flow of energy’ is placed in quotation marks be-
cause the meaning of this phrase cannot be articulated in anye British Mycological Society. This is an open access article under
450 N. P. Moneysuccinctmanner.)Westernmedicine addresses some forms of
heart disease very differently, by prescribing drugs that reduce
blood pressure and serum cholesterol, and recommending
changes in diet and exercise. The use of a combination of ther-
apies inChinesemedicine,which is often adjusted for eachpa-
tient, makes it difficult tomeasure the particular usefulness of
shiitake mushrooms in a clinical trial.
A handful of experiments on the properties of specific
chemical compounds extracted from shiitake have been
promising (Memorial Sloan Kettering Cancer Center [MSKCC]
MSKCC 2015a).1 Lentinan is a b-(1 / 3)-D-glucan in the cell
walls of the masses of hyphae that form the shiitake fruit
body (Zhang et al. 2011). Lentinan research has demonstrated
that the molecule acts as an adjuvant that stimulates the pro-
duction of antibodies in mice injected with a vaccine against
hepatitis B. Other experiments on tissue cultures show that
lentinan stimulates cells of the immune system to attack can-
cer cells and cells infected with viruses. In a rare instance of
a clinical trial using a mushroom extract, Japanese re-
searchers found that patients receiving chemotherapy for ad-
vanced stomach cancer survived longer if lentinan was added
to their drug cocktail (Ina et al. 2013). These results fall short of
proving that shiitake is useful in cancer therapy, but they cer-
tainly encourage further study.
The lentinan research appears, at first glance, to buttress
the historical case for using mushrooms, but there are some
important caveats. One of the problems is that the results of
studies on single chemical compounds are unlikely to apply
to the consumption of whole fruit bodies or concoctions
made from dried mushroom powder. It is impossible, for ex-
ample, to link the immunological consequences of injecting
mice with cell wall polysaccharides to the expediency of
drinking hot tea brewed from shiitake. Nevertheless, compa-
nies that market herbal medicines exploit references to stud-
ies on mice in their promotion of mushroom capsules and
throat sprays for treating all kinds of ailments. They also
base their trade on the bromide of special knowledge privi-
leged to Asian culture. This cliche should have been retired
a long time ago. It is instructive to consider that life expec-
tancy in China increased from 35 y in the 1940s, to 75 today.
Many factors contribute to this phenomenal demographic
change, but the introduction of Western medicine is signifi-
cant (Zhou et al. 2015). Chinese people choose Western medi-
cine when they are diagnosed with serious illnesses today.
As the Chinese embrace modern medicine, the global ap-
petite for herbal medicines has moved in the opposite direc-
tion. Annual sales of these products account for a big chunk
of the widermarket for nutritional supplements that is valued
at $50 billion and seems impervious to the economic instabil-
ity that has affected other business sectors (Harrison-Dunn
2014). This profitable trade provides a powerful incentive for
companies to test the credulity of their customers and1 The Integrative Medicine links on the website of the
Memorial Sloan Kettering Cancer Center in New York provide
an objective analysis of hundreds of ‘herbs, botanicals, and
other products’ that have purported uses in the treatment of can-
cer. Each webpage dedicated to a medicinal mushroom species
has an up-to-date list of references to clinical studies
(https://www.mskcc.org).unsupported assertions have come to define the medicinal
mushroom business.
The bracket fungus Ganoderma lucidum, called lingzhi (in
China) and reishi (in Japan), is one of the most popular medic-
inal mushrooms and has a history of use in China that is even
older than the regional enthusiasm for shiitake. Lingzhi is
mentioned in a 2000-year-old poem from the Han dynasty
and earlier descriptions of the ‘Mushroom of Immortality’
probably refer to this species. The fungus grows on rotting
wood in the wild and modern farmers raise the fungus on
sawdust pellets or straw packed into plastic bags (Fig 1). Like
shiitake, lingzhi is believed to have an immense range of ben-
efits and is used to treat cancer, seizures, cardiovascular prob-
lems, and diabetes (Wachtel-Galor et al. 2011). Comprehensive
reviews of the available evidence dampen enthusiasm for
lingzhi, offering no support for the use of this mushroom in
treating heart disease or cancer (Jin et al. 2012; Klupp et al.
2015; MSKCC 2015b). Investigators reached identical conclu-
sions in their evaluation of the extensive studies on the little
bracket fungus, Trametes versicolor, called turkey tail (MSKCC
2015c).
Chaga, Inonotus obliquus, grows as a rock-hard excrescence
from birch trees. This dense structure is a sclerotium rather
than a fruit body. The powdered sclerotia of chaga have
been used as a folk remedy against cancer and the fungus is
mentioned in Aleksandr Solzhenitsyn’s brilliant and disturb-
ing novel ‘CancerWard’ (Solzhenitsyn 1969). Reviewing exper-
iments showing the effects of chaga extracts on cultured cells,
the Memorial Sloan Kettering Cancer Center in New York con-
cluded, ‘No clinical trials have been conducted to assess cha-
ga’s safety and efficacy for disease prevention or for the
treatment of cancer, cardiovascular disease, or diabetes’
(MSKCC 2015d). Much the same applies to maitake, Grifola
frondosa, also known as hen of the woods, which is a polypore
that grows as masses of fruit bodies at the base of oak trees
(MSKCC 2015e). The only thing that we can say with confi-
dence is that extracts from shiitake, lingzhi, turkey tail, chaga,
and maitake stimulate cells in tissue culture experiments.
The ascomycete Ophiocordyceps sinensis is another fungus
associatedwith a range of pharmacological properties, includ-
ing its effectiveness at reversing altitude sickness and erectile
dysfunction. The 2013 harvest of 50 tonnes of this wild fungus
in the Tibetan Autonomous Region was valued at $1.2 billion,
but scientific evidence for its diversemedicinal applications is
lacking (Anon 2015; MSKCC 2015f).
With so little critical study of the benefits of medicinal
mushrooms, it is alarming that the potential harm done by
these natural products has been neglected. A few studies sug-
gest that any side effects of mushroom extracts are not seri-
ous (Klupp et al. 2015), but cases of food allergy, cheilitis
(inflammation of the lips), flagellate erythema, and liver dam-
age have been reported in the literature (Yuen et al. 2004;
Mukai et al. 2006; Suehiro et al. 2007; Wanmuang et al. 2007;
Goikoetxea, Fernandez-Benıtez, Sanz 2009; Girard & Bessis
2010). Contamination of harvested mushrooms by toxigenic
fungi and bacteria is another concern for consumers
(Ahmad et al. 2014).
Themedicinalmushroomproduct range of Fungi Perfecti,
a company based in Washington State, includes a variety of
capsules and bottled fluids that contain extracts from the
Fig 1 e Lingzhi or reishi, Ganoderma lucidum, cultivated on bags filled with sawdust. Source: Ceekchean Tan, with
permission.
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(www.fungi.com 2015). The use of cultures rather than fruit
bodies is interesting in itself, requiring consumers to accept
that the active compounds in the mushrooms are generated
in a constitutive fashion so that they also present themselves
in the vegetative hyphae (Bak et al. 2014; Konno et al. 2014).
Putting this complication aside, the company says that
‘Healthy respiratory support’ is furnished by a mixture of
reishi and other mushrooms; chaga extract covers ‘Antioxi-
dant and DNA support’, and maitake offers the promise of
helping to ‘maintain healthy blood sugar levels.’ Another
group of products targets particular parts of the body, with
one dietary supplement addressing ‘breast health’, another
affecting the brain (‘helps to support mental clarity’), and
a third dealing with the liver. The list of ingredients in these
supplements includes mushrooms that support ‘immune
function’ (turkey tail) and ‘hormonal and adrenal function’
(lingzhi). An asterisk accompanies every property, referencing
the following manufacturer’s disclaimer: ‘These statements
have not been evaluated by the Food and Drug Administra-
tion. This product is not intended to diagnose, treat, cure or
prevent any disease.’ This is like making bicycles and telling
customers that they are not meant to be ridden!
Fungi Perfecti is one of many companies that market me-
dicinal mushrooms and its product claims are quite modest
compared with endorsements provided by other peddlers of
naturopathic medicines. If something is sold for the purpose
of improving heart health, it seems reasonable that there
should be evidence for its potency and that this information
should be available to the public. Unlike prescription medi-
cines, medicinal mushrooms have escaped these require-
ments, which means that a fruit body extract can be sold in
the United States for the stated purpose of ‘comprehensiveimmune support’, or just about anything else, as long as the
company provides the standard disclaimer. The laws in
Europe are even looser, allowing companies in the United
Kingdom tomarketmedicinalmushroomswithout employing
a legal rider.
The medicinal mushroom industry is aware of growing
criticism and many companies have scaled back the claims
in their advertisements to protect themselves from lawsuits.
Until quite recently, some catalogues listed extracts from cul-
tures of mushroom mycelia for the treatment of cancer and
other serious diseases. Few companies make these claims di-
rectly today, even under the protection of the asterisk.
Themajority of prescription drugswork by affecting partic-
ular biochemical pathways. The best-selling medicines for re-
ducing cholesterol levels and blood pressure work by
inhibiting single enzymes, and antibiotics disrupt specificmo-
lecular processes in bacterial cells. None of these drugs are
perfect and all of them can produce unpleasant side effects.
But most of them work as advertised and the manufacturers
can be held liable if their products harm consumers. Horrify-
ing errors have been made in licensing some medicines, and
the pharmaceutical industry wins few awards for altruism,
but, warts and all, prescription drugs are a perfect reflection
of the ethos of Western medicine. Anyone whose life has
been saved by antibiotic therapy must agree that the discov-
ery and development of the b-lactams and later generations
of antibiotics represents one of the greatest achievements of
the modern era.
Pursuing this critical exploration ofmedicinalmushrooms,
it seems very likely that mushrooms do contain compounds
with important pharmacological properties. This optimism
is encouraged by the deep history of interactions between
fruit bodies and potentially fungivorous animals. The ability
452 N. P. Moneyof fruit bodies to survive damage by insects and other pests
long enough to release spores suggests that they generate
a range of cryptic antifeedants that interact with molecular
targets in animals. Toxins and neurotropic compounds syn-
thesized by fruit bodies are obvious examples of mushroom
products with extraordinary pharmacological activities. Dis-
regarding the dafter ideas about medicinal mushrooms, it is
possible that these fungi offer a treasure trove of uncharacter-
ized metabolites that could prove useful in treating our
illnesses.
The work on ubiquitous compounds like lentinan from
shiitakemay be a distraction from thework of bioprospecting.
Lentinan is a version of a polysaccharide that is found in all
fungi. Although it is possible that there is something special
about the chemical structure of lentinan, b-glucans extracted
from any mushroom are likely to have the same medicinal
properties, or lack thereof, as lentinan. Shiitake may have
been adopted in China for the simple reason that it was easy
to cultivate. A better model for future research on medicinal
mushrooms is provided by a pair of molecules identified in
lion’s mane, Hericium erinaceus. This is another mushroom
that has been used in China for centuries. It is cultivated on
sawdust pellets like lingzhi (Fig 2). This species has become
associated with the unusual characteristic of promoting neu-
rological health, which attracts a lot of attention in our time of
aging populations and the spectre of Alzheimer’s disease. The
active compounds extracted from lion’s mane are called eri-
nacines and hericenones. Erinacines and hericenones stimu-
late the release of nerve growth factor in rat brains and
cultured nerve cells (Ma et al. 2010). This effect seems worthy
of additional analysis.
Theworst of the advertisements formedicinalmushrooms
recall the era of medical quackery that tolerated patent med-
icines including ‘Dr. Bonker’s Celebrated Egyptian Oil’, which
was advertised as a cure for colic and cramps in humans and
farm animals, and ‘Dr. Solomon’s Cordial Balm of Gilead’
that was praised as a treatment for venereal disease and
a plethora of other maladies (Helfand 1989). Putting aside
the current fantasies about mushrooms, there are goodFig 2 e Lion’s mane, Hericium erinaceus, cultivated on bags of
sawdust and wood chips. Source: Nutthawit Wiangya, with
permission.reasons for surveying the galaxy of metabolites in these or-
ganisms. After all, other kinds of fungi are the source of anti-
biotics old (penicillin) and new (cephalosporins), the
cholesterol-lowering drug lovastatin, and cyclosporins for
supporting patients after organ transplants (Watkinson,
Boddy, Money 2015). Miraculous drugs may be sitting in the
least prepossessing fruit bodies. And with a choice of 16 000
or more species of basidiomycetes that form mushrooms,
there are lots of places to look. It is time to treat anti-aging
tonics made from mushrooms as a sad phase in the history
of mycology and proceed with the exploration of novel com-
pounds with the potential to change the course of our modern
plagues.Disclaimer
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